FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Baxter Healthcare Acetaminophen Injection Recall

Acetaminophen Injection, 10 mg/mL, 1,000 mg/100 mL, 100 mL VIAFLO container bag, Single…

Baxter Healthcare Corporation · Deerfield, IL

Risk level
Class II
Reported by FDA
Aug 24, 2022
Recall ID
D-1348-2022
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled Acetaminophen Injection starting Aug 4, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1348-2022 on Aug 24, 2022. Reason: Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment. Status: Terminated.

Why it was recalled

Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.

Product description

Acetaminophen Injection, 10 mg/mL, 1,000 mg/100 mL, 100 mL VIAFLO container bag, Single Dose Container, For Intravenous Use Only, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; NDC 36000-306-60

Lot numbers, UPCs & expiration codes

Lots: 20K19G64T1, Exp 10/31/2022; 21K23G65, 21K25G65, 21K26G65, 21K29G67, Exp 10/31/2023; 21L10G65, 21L13G66, 21L14G66, 21L15G65, Exp 11/30/2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1348-2022
Classification
Class II
Status
Terminated
Recall initiated
Aug 4, 2022
FDA report date
Aug 24, 2022
Quantity
85,680 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corporation

Original FDA data

Every field from FDA enforcement report D-1348-2022, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
90699
Address
1 Baxter Pkwy
Code information
Lots: 20K19G64T1, Exp 10/31/2022; 21K23G65, 21K25G65, 21K26G65, 21K29G67, Exp 10/31/2023; 21L10G65, 21L13G66, 21L14G66, 21L15G65, Exp 11/30/2023
Postal code
60015-4625
Report date
Aug 24, 2022
Product type
Drugs
Recall number
D-1348-2022
Classification
Class II
Recalling firm
Baxter Healthcare Corporation
Product quantity
85,680 bags
Termination date
Jul 16, 2024
Reason for recall
Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Acetaminophen Injection, 10 mg/mL, 1,000 mg/100 mL, 100 mL VIAFLO container bag, Single Dose Container, For Intravenous Use Only, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; NDC 36000-306-60
Distribution pattern
Nationwide in the USA
Recall initiation date
Aug 4, 2022
Initial firm notification
Letter
Center classification date
Aug 16, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1348-2022, published Aug 24, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls